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ABSTRACT
Objective: In this advanced era of surgery, laparoscopic hysterectomy operations are very commonly practiced by surgeons. It reduces trauma, 
morbidity, and health-care costs, ensuring early discharge. However, the early post-operative pain experienced by patients may sometimes negate 
all the advantages of a laparoscopic procedure. Intraperitoneal (IP) instillation of local anesthetics has been proposed to decrease post-operative 
pain after laparoscopic surgeries. Additives to local anesthetics like α-2 agonists such as clonidine and dexmedetomidine prolong the duration of 
analgesia. Therefore, this randomized, prospective, controlled study was conducted to compare the analgesic efficacy of IP ropivacaine with or without 
dexmedetomidine for postoperative analgesia after total laparoscopy hysterectomy.
Methods: At the end of laparoscopic hysterectomy, in a double-blind, randomized manner, one of the following injections was given intraperitoneally. 
The patients were allocated into the following two groups: The patients in ropivacaine group (R group) (N = 40) were given 38 ml of 0.2% ropivacaine 
plus 2 ml of normal saline (NS) and the patients in ropivacaine plus dexmedetomidine group (RD group) (N = 40) were given 38 ml of 0.2% ropivacaine 
combined with 0.5 µg/kg dexmedetomidine (diluted in 2 ml NS) through trocars. All the patients were given diclofenac sodium when they had a pain 
score of 4 on visual analog scale (VAS).
Results: VAS score at different time intervals was significantly lower after the second postoperative hour, time to first request of analgesia (minutes) 
was longest (487.7±40.96 vs. 242.5±19.84), and the total analgesic consumption (mg) was lowest (61.88±37.55 vs. 183.75±44.78) in RD group than 
in R group.
Conclusion: The antinociceptive effects of the IP instillation of ropivacaine in combination with dexmedetomidine are superior to ropivacaine alone 
in laparoscopic hysterectomy cases.
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INTRODUCTION
Laparoscopic procedures have revolutionized gynecological surgeries 
and have almost replaced traditional open surgeries. It has many 
advantages over open surgeries, with smaller and more cosmetic 
incisions, reduced blood loss, reduced pain, early mobility, and early 
enteral feed, hence there will be reduced hospital stay [1,2]. However, 
patients undergoing laparoscopic surgeries experience early post-
operative pain which may require proper attention. Pain intensity 
usually peaks during the first postoperative hours [3]. Pain following 
laparoscopy is multifactorial, with visceral pain being worse than 
abdominal wall pain. Pain results from stretching of intra-abdominal 
cavity, peritoneal inflammation, and diaphragmatic irritation caused by 
residual carbon dioxide in peritoneal cavity [4-6]. Providing adequate 
postoperative analgesia while meeting the criteria for discharge on the 
same day is a challenge.
Recently, the use of local anesthetics for postoperative pain relief in 
laparoscopy has become a popular technique. It provides adequate 
analgesia without any side effect unlike intravenous opioids. 
Intraperitoneal (IP) instillation of local anesthetic agents alone [7] or in 
combination with opioids [8,9] and α-2 agonists such as clonidine [10] 
and dexmedetomidine [11] has been found to reduce post-operative 
pain following laparoscopic gynecological surgeries.
This prospective controlled study was conducted to compare the 
analgesic efficacy of IP ropivacaine with or without dexmedetomidine 
for postoperative analgesia after total laparoscopic hysterectomy.
METHODS
This is a prospective randomized controlled study conducted from 
November 2015 to June 2016 at IMS and SUM Hospital with due 
consent of patients. A total of 80 patients aged 45-65 years of the 
American society of Anesthesiologists physical status score (ASA) I 
and II, scheduled for total laparoscopic hysterectomy, were included 
in the study. Exclusion criteria were as follows; hypersensitivity to 
ropivacaine, acute cholecystitis, weight <45 kg or >100 kg, history of 
previous abdominal surgery, ASA class 3 or 4, endocrine disorders such 
as diabetes mellitus, and patients with severe cardiac or pulmonary 
diseases.
Patients were randomly divided into two equal groups (n=40). 
Randomization was done by computer-generated random numbers 
sealed in envelope, which was distributed by resident doctors 
during Pre-anaesthetic check up (PAC), in which patients received 
IP ropivacaine 38 ml 0.2% + 2 ml normal saline (NS) in Group R and 
ropivacaine 38 ml 0.2% + dexmedetomidine 0.5 µg/kg (diluted in 2 ml 
NS) in Group RD before removal of trocar at the end of surgery.
A conventional balanced general anesthesia was administered to all 
patients. Glycopyrrolate (0.2 mg) and midazolam (0.03 mg/kg) were 
given as premedication. General anesthesia was induced with propofol 
and fentanyl (2 µg/kg). Tracheal intubation was facilitated with 
vecuronium (0.06 mg/kg). Anesthesia was maintained with O2 and air 
(50-50%) and isoflurane at 1 Minimum Alveolar Concentration (MAC). 
Muscle relaxation was maintained by additional doses of vecuronium 
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as and when required. All patients received ranitidine and ondansetron 
as antiemetics. Monitoring included heart rate, respiratory rate, 
continuous ECG, NIBP, SpO2, and EtCO2. All surgeries were performed 
in Trendelenburg position. Intra-abdominal pressure of CO2 was kept 
stable at 10-12 mmHg in all cases. A volume of 40 ml drug solution was 
given as IP instillaion. After peritoneal wash and suction, 10 ml drug 
solution was instilled on the inferior aspect of each diaphragm and the 
rest 20 ml at the operative site through the umbilical port.
The quality of analgesia was determined by visual analog scale (VAS) 
for 24 hrs. Post-operative pain scores were recorded by independent 
resident doctors at ½ hr, 1 hr, 2 hrs, 4 hrs, 8 hrs, 12 hrs, and 24 hrs. 
Post-operative analgesia was standard in all groups. When VAS score 
was >4, patients were given diclofenac sodium (75 mg IV). Time to first 
request of analgesia, total dose of analgesic required in the first 24 hrs, 
and any adverse effect such as nausea and vomiting and shoulder tip 
pain were noted.
Statistical analysis was performed using SPSS software version 12. 
Continuous data were described as mean±standard deviation (SD), and 
Categorical data were presented as absolute numbers or percentage. 
Continuous variables were compared using Student’s independent t-test. 
Chi-square tests were used to match the demographic data of two groups. 
All data were presented as mean±SD, percentage (%), or number.
Observation
The two groups were comparable for age, weight, and duration of 
surgery (Table 1). All patients in both groups underwent laparoscopic 
hysterectomies successfully without any requirement to conversion to 
open operation; hence, there were no dropouts from any group.
The mean VAS scores of group RD were significantly lower at all 
time intervals except till the 2nd hr postoperatively when compared 
to group R (p<0.05) (Table 2). At 24th hr, the difference between VAS 
scores of the two groups was statistically significant (p=0.00) (Table 2).
Time to requirement of the first rescue analgesia was 
487.7±40.96 minutes in group RD as compared to 242.5±19.84 minutes 
in group R (p=0.00) (Table 3). The mean total consumption of diclofenac 
in RD group was at an average of 61.88±37.55 mg, while in ropivacaine 
group, it was 183.75±44.78 mg, which was statistically significantly high 
(p=0.00) (Table 3). All patients received rescue analgesia in group R at 
various time intervals whereas only 62% of the patients in group RD 
received rescue analgesia.
The side effects such as nausea and vomiting were also less in RD group 
than in ropivacaine group, but the difference noted was not statistically 
significant (p>0.05) (Table 4).
DISCUSSION
Laparoscopic surgeries are nowadays practiced as day care procedures. 
Thus, providing adequate post-operative pain relief is considerably 
important, as patients need to be discharged on the same day or another 
day. Previous studies prove that though laparoscopy is a minimally 
invasive procedure, certain degree of pain is still experienced by 
patients. Pain can be multifactorial arising from incision site (somatic 
pain), from surgical site (visceral pain), and due to pneumoperitoneum 
(referred pain) [12]. Out of the different regimens proposed for 
post-operative pain such as intravenous NSAIDS, opioids, and local 
infiltration, IP infiltration of local anesthetic has been chosen by many 
surgeons as an effective modality. The rationale for this route is that 
visceral nociceptive conduction is blocked. The local anesthetic inhibits 
nociception by affecting nerve membrane-associated proteins and by 
inhibiting the release and action of prostaglandins and other agents 
that sensitize the nociceptors and contribute to inflammation [11]. 
However, absorption from large peritoneal surface may also occur 
and this may be a further mechanism of analgesia. Local anesthetics 
have been administered into peritoneal cavity during laparoscopic 
cholecystectomy and gynecological laparoscopy for sterilization and 
diagnosis, in addition to open abdominal procedure such as total 
abdominal hysterectomy [13]. This technique was first evaluated 
in patients undergoing gynecological laparoscopic surgery [14]. Its 
application in laparoscopic cholecystectomy was initially examined 
in a randomized trial in 1993 [15]. The main advantage of using local 
anesthetics is that they do not have the adverse effect of opioids, which 
may delay recovery and discharge from hospital.
Bupivacaine has been used most widely for treating post-operative 
analgesia after laparoscopic cholecystectomy. Ropivacaine , a new long-
acting amide local anesthetic , is chemically related to bupivacaine, 
but it has been shown to be less toxic to cardiac and central nervous 
systems [16]. Kucuk et al. [9] reported benefit in terms of both post-
operative pain and analgesic consumption using 150 mg ropivacaine. 
IP instillation of 150 mg ropivacaine during gynecological laparoscopy 
produced statistically significant 24 hrs morphine-sparing effect 
compared with placebo. Gupta et al. concluded that ropivacaine 
70 ml (0.25%) infiltrated into cholecystectomy wounds significantly 
decreases wound pain and increases time until the first request 
of post-operative analgesia, without any side effect attributable to 
ropivacaine [17]. Labaille et al. used 100 mg of ropivacaine infiltrated 
intraperitoneally and concluded it to be the optimal dose for reducing Table 1: Demographic data
Groups Age (years) Weight (kg) Duration of 
surgery (minute)
R (n=40) 57.33±5.6 57.63±5.6 110.55±9.4
RD (n=40) 56.55±5.3 58.05±5.32 110.83±2.2
p 0.52 0.4 0.85
n: Number of patients, Kg: Kilograms, values are expressed in mean±SD, 
min: Minutes, SD: Standard deviation
Table 2: Postoperative VAS scores at ½ hr, 1 hr, 2 hrs, 4 hrs, 
8 hrs, 12 hrs, and 24 hrs
VAS score timing R (n=40) RD (n=40) p
½ hr 0.33±0.47 0.25±0.44 0.465
1 hr 1.83±0.54 1.58±0.59 0.054
2 hr 2.23±0.66 0.2.10±0.67 0.404
4 hrs 4.13±0.72 1.48±0.71 0.000
8 hrs 2.35±0.74 1.75±1.28 0.012
12 hrs 4.25±0.54 1.98±1.1 0.001
24 hrs 2.15±0.66 1.6±0.71 0.001
VAS: Visual analog scale, n: Number of patients; values are expressed in 
mean±SD, SD: Standard deviation
Table 3: Comparison of analgesic requirements
Parameters R (n=40) RD (n=40) p
Number of patients given 
rescue analgesia (%)
40 (100) 25 (62.5) 0.001
Mean time for the first 
dose (minutes)
242.5±19.84 487.7±40.96 0.001
Mean total dose (mg) in 
24 hrs
183.75±44.78 61.88±37.55 0.001
n: Number of patients; %: Percentage of patients in each group, mg: Milligrams 
of diclofenac, values are expressed in mean±SD, SD: Standard deviation








Nausea 8 (20) 2 (5) 0.087
Vomiting 3 (7.5) 0 0.07
Shoulder tip pain 2 (5) 0 0.15
n: Number of patients, %: Percentage of patients in each group
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pain after laparoscopic cholecystectomy [8]. One previous study by 
Goldstein et al. reported that the IP instillation of 20 mL of either 
0.5% bupivacaine or 0.75% ropivacaine prevented postoperative pain 
and decreased the need for postoperative analgesia, when compared 
with placebo in patients undergoing laparoscopic gynecologic  [18]. 
Papas-Gogos et al. used 155 mg of ropivacaine, of which 80 mg was 
infiltrated intraperitoneally and the rest was infiltrated at trocar 
wounds. They observed adequate pain relief [19].
 In our study, we used 76 mg ropivacaine (0.2%) for IP instillation in 
one group and mixed it with dexmedetomidine (0.5 µg/kg) in another 
group of patients.
Dexmedetomidine is a highly lipophilic α2 agonist. Its antinociceptive 
effect occurs at dorsal root neuron level. Here, it blocks the release of 
substance P in nociceptive pathway through the action of inhibitory G 
protein, which increases the conductance through K+ channels [20]. 
Dexmedetomidine enhances both central and peripheral neural blockade 
by local anesthetics [21]. Its peripheral neural blockade is due to its 
binding to α2a-AR antibody. Because of the high lipophilic nature of 
dexmedetomidine, it acts over the peritoneal neural receptors and blocks 
the nociceptive stimuli. Memis et al. [22] in 2005 studied the effects of 
tramadol and clonidine added to IP bupivacaine on postoperative pain in 
total abdominal hysterectomy and found it to be better than bupivacaine 
alone. Very few studies in literature have examined the analgesic 
effect of IP dexmedetomidine. Ahmed et al. [23] compared meperidine 
or dexmedetomidine in combination with bupivacaine (0.25%) in 
gynecological laparoscopic surgery and concluded that dexmedetomidine 
group significantly decreased post-operative analgesic requirement. 
Results of our study correlate with the above study.
On analysis of mean scores of group R and group RD, it was observed 
that group RD had better pain relief till 24 hrs postoperatively and this 
was statistically significant (P=0.05), except at ½ hr, at 1 hr, and 2 hrs 
postoperatively when pain scores were not statistically different. Shukla 
et al. had done the same study in laparoscopic cholecystectomy and 
concluded that IP instillation of dexmedetomidine in combination with 
bupivacaine gives better pain relief and reduces analgesic requirement 
as compared to bupivacaine alone [24].
Table 3 shows that in group R, patients required the first dose of rescue 
analgesia by 242.5±19.84 minutes, whereas in group RD, analgesia 
stayed for nearly 487.7±40.96 minutes. However, the VAS score in 
group R was low after 4th hr; this may be due to the administration of 
diclofenac to these patients after 4th hr postoperatively.
In patients receiving ropivacaine and dexmedetomidine, only few 
patients required the second dose of rescue analgesia (Table 4). The 
mean dose of diclofenac consumption was significantly higher in group R 
(183.75±44.78 mg) than in group RD (61.88±37.55 mg). These findings 
suggest that adding dexmedetomidine to ropivacaine intraperitoneally 
significantly decreases analgesic requirement. The above results were 
in agreement with that of Memis et al. and Ahmed et al., but on contrast, 
Memis et al. in their study found higher doses in clonidine group than 
tramadol group. In the present study, dexmedetomidine shows better 
results which might be due to its high selectivity than clonidine.
Regarding adverse effects, nausea and vomiting were found in 8 patients 
in group R and 2 patients in group RD. The result was statistically 
insignificant.
Shoulder tip pain after laparoscopic cholecystectomy occurs in 35-63% 
of the patients [18]. It occurs after diaphragmatic stretching with 
phrenic nerve neuropraxia. The incidence of shoulder pain is markedly 
lower in laparoscopic hysterectomy when compared to laparoscopic 
cholecystectomy [25]. In our study, shoulder tip pain was observed 
only in 2 patients in group R and none in group RD.  Joris et al obtained 
similar results using bupivacaine concluding that using bupivacaine 
intraperitoneally  decreases  incidence of shoulder pain for 24 hrs 
postoperatively.
CONCLUSION
IP instillation of ropivacaine and dexmedetomidine combination 
is an easy and effective mode of providing postoperative analgesia 
in laparoscopic hysterectomy for a longer period and is superior to 
ropivacaine alone without any significant increase in adverse events.
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